Astrana Health, Inc.
ASTH
$29.34
$0.1450.50%
ASTH market cap represents
0.02%
of the sector.
Valuation
ASTH
Low
ASTH
Sector Average
High
Market Cap
1.40B
< 1.40B
> 16.04B
Enterprise Value
1.38B
< 1.38B
> 18.16B
Price/Earnings (TTM)
22.49
< 0.00
> 30.00
Earnings Per Share Growth (TTM)
37.52%
< -50.00%
> 40.00%
Price/Earnings To Growth (TTM)
0.60
0.00
> 10.00
Price/Sales (TTM)
0.82
< 0.00
> 330.00
Price/Book (Q)
1.98
< 0.00
> 30.00
Enterprise Value/Revenue (TTM)
0.80
< 0.00
> 140.00
Enterprise Value/EBITDA (TTM)
12.62
< -10.00
> 20.00
Enterprise Value/EBIT (TTM)
16.30
< 0.00
> 20.00
Dividends and Shares
ASTH
Low
ASTH
Sector Average
High
Shares Outstanding
48.22M
< 40.00M
> 250.00M
Dividend Per Share (Most Recent)
--
0.00
2.38
Dividend Per Share (TTM)
--
0.00
9.13
Dividend Yield (TTM)
--
0.00%
7.71%
Payout Ratio (TTM)
95.76
< 10.00
> 100.00
Price History
ASTH
Low
ASTH
Sector Average
High
Beta
1.38
< -10.00
5.83
1-Month Total Return
-25.06%
< -30.00%
> 0.00%
3-Month Total Return
-20.65%
< -30.00%
> 0.00%
6-Month Total Return
-47.02%
< -50.00%
> 10.00%
Year to Date Total Return
-9.33%
< -20.00%
> 0.00%
1-Year Total Return
-27.18%
< -30.00%
> 10.00%
2-Year Total Return
-18.47%
< -20.00%
> 440.00%
3-Year Total Return
-19.53%
< -20.00%
> 0.00%
5-Year Total Return
205.71%
< 50.00%
> 210.00%
Profitability
ASTH
Low
ASTH
Sector Average
High
Operating Margin (TTM)
4.92%
< -4,830.00%
> 10.00%
Profit Margin (TTM)
3.62%
< -4,080.00%
> 10.00%
Management Effectiveness
ASTH
Low
ASTH
Sector Average
High
Return on Assets (TTM)
4.49%
< -50.00%
> 10.00%
Return on Equity (TTM)
10.26%
< 10.00%
> 60.00%
Income Statement
ASTH
Low
ASTH
Sector Average
High
Revenue (TTM)
14.82M
< 10.00M
> 12.32B
Total Revenue (TTM)
1.72B
< 1.72B
> 12.49B
Total Revenue Growth (Q YOY)
37.49%
< 30.00%
> 1,440.00%
Revenue Per Share (TTM)
35.72
< 30.00
> 200.00
Gross Profit (TTM)
259.89M
< 250.00M
> 3.73B
EBITDA (TTM)
109.46M
< 100.00M
> 1.10B
EBIT (TTM)
84.76M
< 80.00M
> 730.00M
Net Income (TTM)
62.46M
< 60.00M
> 270.00M
Net Income Avl. to Common (TTM)
62.46M
< 60.00M
> 270.00M
Earnings Growth (Q YOY)
-32.15%
< -280.00%
> -30.00%
EPS Diluted (TTM)
1.30
< -5,460.00
> 10.00
EPS Diluted Growth (Q YOY)
-29.79%
< -30.00%
> 0.00%
Balance Sheet
ASTH
Low
ASTH
Sector Average
High
Cash and Short-Term Inv. (Q)
350.35M
< 340.00M
> 1.37B
Cash Per Share (Q)
7.27
0.00
> 200.00
Total Current Assets (Q)
596.99M
< 590.00M
> 3.45B
Total Assets (Q)
1.29B
< 1.28B
> 9.77B
Total Current Liabilities (Q)
312.93M
< 310.00M
> 2.57B
Total Debt (Q)
475.97M
< 470.00M
> 3.14B
Total Liabilities (Q)
778.27M
< 770.00M
> 6.13B
Total Common Equity (Q)
704.62M
< 700.00M
> 3.54B
Total Preferred Equity (Q)
--
0.00
920.42M
Total Equity (Q)
507.11M
< 500.00M
> 3.64B
Current Ratio (Q)
1.908
0.009
> 20.000
Book Value Per Share (Q)
14.75
< 10.00
> 2,160.00
Cash Flow
ASTH
Low
ASTH
Sector Average
High
Cash from Operations (TTM)
82.45M
< 80.00M
> 720.00M
Cash from Investing (TTM)
-170.50M
< -590.00M
> -140.00M
Cash from Financing (TTM)
162.41M
< -190.00M
> 170.00M
Net Change in Cash (TTM)
74.35M
< -40.00M
> 80.00M
Levered Free Cash Flow (TTM)
124.77M
< 120.00M
> 540.00M
The comparison requires a security to have a minimum 30 day average trading volume of 100,000 at $1 or over, or a $5 minimum price.
* Lowest and highest value for any one individual security in the sector.
